Results summary | View all lists in L2L MDB | View all genes in C05AD.profile.ud50 |
Reduced expression in XPC-defective fibroblasts, compared to normal fibroblasts, following treatment with cisplatin enrichment: 3.34-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
201978_S_AT | KIAA0141 | ![]() |
![]() |
KIAA0141 | |||||||||
207920_X_AT | ZFX | R | ![]() |
![]() |
zinc finger protein, X-linked | ||||||||
205063_AT | SIP1 | R | ![]() |
![]() |
survival of motor neuron protein interacting protein 1 | ||||||||
215990_S_AT | BCL6 | G | D | X | R | C | S | ![]() |
![]() |
B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||
202435_S_AT | CYP1B1 | E | ![]() |
![]() |
cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||
209277_AT | TFPI2 | X | ![]() |
![]() |
tissue factor pathway inhibitor 2 |